ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 582,94
-0,65%
Dow Jones
40 211,72
0,53%
DAX
18 502,38
-0,53%
Brent Oil
83,725
-0,73%
Bitcoin
63 151,91
-2,62%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
27/11/201816h06Business WireTeva’s Generic Version of EpiPen® (Epinephrine Injection, USP) Auto-Injector 0.3 mg Now Available in Limited Quantity in ...NYSE:TEVATeva Pharmaceutical Industries Ltd
01/11/201815h19Dow Jones NewsTeva Shares Rise as Investors Greet Progress in TurnaroundNYSE:TEVATeva Pharmaceutical Industries Ltd
01/11/201813h16Dow Jones NewsTeva 3Q Sales Fell 19%NYSE:TEVATeva Pharmaceutical Industries Ltd
01/11/201812h00Business WireTeva Reports Third Quarter 2018 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201814h23Business WireTeva and New Jersey Governor Murphy Formalize North America Headquarters Move with Ceremony in IsraelNYSE:TEVATeva Pharmaceutical Industries Ltd
12/10/201819h30Dow Jones NewsMylan Gets Favorable Appeals Court Ruling in Patent Dispute Over Teva's CopaxoneNYSE:TEVATeva Pharmaceutical Industries Ltd
11/10/201811h00Business WireTeva nutzt Patientenerfahrungen zur Unterstützung von Patienten mit chronischen ErkrankungenNYSE:TEVATeva Pharmaceutical Industries Ltd
11/10/201811h00Business WireTeva Draws on Patient Experience to Empower Those Living with Chronic ConditionsNYSE:TEVATeva Pharmaceutical Industries Ltd
10/10/201818h30Business WireCelltrion & Teva Announce FDA Oncologic Drugs Advisory Committee Recommends Approval of Celltrion BLA for CT-P10, a Proposed ...NYSE:TEVATeva Pharmaceutical Industries Ltd
10/10/201817h00Business WireTeva Presents 25-year Safety Data from Longest Continuous Trial of COPAXONE® (glatiramer acetate injection) for the Treatmen...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/10/201813h00Business WireTeva to Present New Data at 34th European Committee for Treatment and Research in Multiple Sclerosis Congress in BerlinNYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/201813h00Business WireTeva to Report Third Quarter 2018 Financial Results on November 1, 2018NYSE:TEVATeva Pharmaceutical Industries Ltd
04/10/201808h38Dow Jones NewsMedincell IPO to Raise Up to EUR32.5 MillionNYSE:TEVATeva Pharmaceutical Industries Ltd
27/09/201821h49Dow Jones NewsTeva Launches Generic Version of Cialis in the U.S.NYSE:TEVATeva Pharmaceutical Industries Ltd
27/09/201821h00Business WireTeva Announces Exclusive First-to-File Launch of a Generic Version of Cialis® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
20/09/201822h14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
18/09/201813h00Business WireTeva Announces Early Results of Debt Tender Offer and Election of Early SettlementNYSE:TEVATeva Pharmaceutical Industries Ltd
15/09/201804h00Business WireADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First & Only Anti-CGRP Treatment...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/09/201802h35Dow Jones NewsFDA Approves Teva's Migraine Drug Ajovy -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
15/09/201802h14Dow Jones NewsFDA Approves Teva's Migraine Drug AjovyNYSE:TEVATeva Pharmaceutical Industries Ltd
15/09/201800h48Business WireTeva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First & Only Anti-CGRP Treatment with Both Quarter...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/09/201818h28Business WireTeva to Present at the Morgan Stanley Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
12/09/201809h15Dow Jones NewsIndivior: Sublocade Uptake Picking UpNYSE:TEVATeva Pharmaceutical Industries Ltd
10/09/201819h58Dow Jones NewsAcorda Shares Tumble After Court RulingNYSE:TEVATeva Pharmaceutical Industries Ltd
10/09/201818h41PR Newswire (Canada)Teva Canada annonce le lancement d'une version générique de (Pr)Abilify(MD) : les comprimés(Pr)Teva-Aripiprazole pour le t...NYSE:TEVATeva Pharmaceutical Industries Ltd
10/09/201818h10PR Newswire (Canada)Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR)Teva-Aripiprazole Tablets for the treatment of Sc...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/201800h09Dow Jones NewsFDA Approves TEVA's Cassipa to Treat Opioid DependenceNYSE:TEVATeva Pharmaceutical Industries Ltd
06/09/201822h05PR Newswire (US)Teva, NACHC and Direct Relief Provide Important Insights on Prescription Medicine Access for Underserved Patients at the AAM ...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/09/201817h44Business WireTeva Announces $400 Million Debt Tender OfferNYSE:TEVATeva Pharmaceutical Industries Ltd
25/08/201815h29Dow Jones NewsEpiPen Shortage Hits Back-to-School SeasonNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NASDAQ
OXLCP
Oxford Lane Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés